Rheumatoid arthritis in thalassemia intermedia: Coincidence or association?

Israel Medical Association Journal

Volumn 7, Issue 10, 2005, Pages 667-669

  Giakoumi, Xanthi ^a,b   Tsironi, Maria ^a,b   Floudas, Charalampos ^a,b   Polymeropoylos, Evangelos ^a,b   Papalambros, Efstathios ^a,b   Aessopos, Athanassios ^a,b  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chelation; Rheumatoid arthritis; Thalassemia intermedia

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCIUM; CHELATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; VITAMIN D;

ADULT; ANEMIA; ARTHRALGIA; BETA THALASSEMIA; BLOOD CELL COUNT; BLOOD SMEAR; BLOOD TRANSFUSION; BONE EROSION; CASE REPORT; COMORBIDITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENETIC ANALYSIS; HEART MURMUR; HUMAN; LEG ULCER; MORNING STIFFNESS; OSTEOPOROSIS; REVIEW; RHEUMATOID ARTHRITIS; SPLENECTOMY; SUBCUTANEOUS NODULE; TACHYCARDIA;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BETA-THALASSEMIA; CHELATION THERAPY; FEMALE; HUMANS;

EID: 27144504905     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Aessopos A, Samarkos M, Voskaridou E, et al. Arterial calcifications in beta-thalassemia. Angiology 1998;49(2):137-43.
2. Berkovitch M, Laxer RM, Inman R, et al. Arthropathy in thalassaemia patients receiving deferiprone Lancet 1994;343 (8911):1471-2.
3. Ezer U, Gulderen F, Culha VK, Akgul N, Gurbuz O. Immunological status of thalassemia syndrome. Pediatr Hematol Oncol 2002;19(1):51-8.
4. Bowlus CL.The role of iron in T cell development and autoimmunity. Autoimmun Rev 2003;2(2):73-8.
5. Castellino G, Govoni M, Trotta F. Rheumatoid arthritis in β-thalassaemia trait. Rheumatology (Oxford) 2000;39(11):1286-7.